Delivery Order SPE2DR25D2206-SPE2DR26F9ED1
- Not listed
- The Defense Logistics Agency awarded a $1,838.49 delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Adderall 10 mg tablets in quantities of 100. This firm fixed-price delivery order, with an ultimate completion date of December 9, 2025, represents a non-competitive set-aside contract issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a $12,063.51 delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Adderall 10 mg tablets (100-count units), with an ultimate completion date of December 8, 2025. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,160.91 for 100 tablets of Adderall 15 mg on July 18, 2025, with completion scheduled for July 21, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Adderall 15 mg tablets in quantities of 100 units, with a ceiling value of $11,296.62. This competitively awarded, firm fixed-price delivery order is set to be completed by August 5, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a small-value transaction within AmerisourceBergen's broader federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Adderall 15 mg tablets (100-count units) with a ceiling value of $7,185.94 under a firm fixed-price contract. This non-set-aside delivery order is scheduled for completion by December 5, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,325.97 for 100 tablets of Adderall 30mg on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,939.56 to AmerisourceBergen Drug Corp for the supply of Adderall 15 mg tablets (100-count units) on September 18, 2025, with completion expected by September 19, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a routine pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a $1,187.88 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Adderall XR 10mg under a firm fixed price contract. This non-competitive delivery order, issued on November 18, 2025, with a completion date of the same day, represents a pharmaceutical supply fulfillment supporting federal medical procurement needs. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $2,077.30 delivery order from the Defense Logistics Agency for 100 tablets of Adderall 20 mg. Awarded on December 2, 2025, with an ultimate completion date of December 3, 2025, this firm fixed-price contract represents a non-competitive, non-set-aside award. The contract is classified as a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $3,271.04 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Adderall 10 mg, with delivery completion required by December 10, 2025. This competitive award employs firm fixed-price terms and carries no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor and healthcare solutions provider....
- SPE2DR25D2206Indefinite Delivery Contract
- SPE2DR25D2206-SPE2DR26F9ED1Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,158.60 for 100 tablets of Adderall 15 mg on December 3, 2025, with completion scheduled for December 4, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical supply transaction under AmerisourceBergen's comprehensive $999.99 billion IDC with the Defense Logistics Agency, which extends through December 2026 and authorizes the distributor to supply a broad range of medications, vaccines, and medical supplies to support military healthcare systems globally. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen maintains an extensive portfolio of federal contracts supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through open competition. The award demonstrates the company's continued role as a primary supplier of pharmaceutical commodities across multiple therapeutic domains for military and veteran healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 12/2/25 |